Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"), a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that it has manufactured its CannaCaviar line of cannabidiol (CBD) soft gels, which will be available for sale later this week. CannaCaviar is Tauriga's second product that utilizes cannabidiol (CBD) oil extracted from non-GMO industrial hemp as its key ingredient. The Company also sells TopiCanna, a proprietary topical medicinal cannabis cream. Many who have used topical cannabis creams have reported decreased musculoskeletal pain. Both TopiCanna and CannaCaviar are designed to provide potential natural wellness and healing properties without psychoactive effects.
http://money.cnn.com/news/newsfeeds/articles/prnewswire/NE38086.htm
No comments:
Post a Comment